The advent of microfluidic technology as a basic tool for chemical synthesis is slowly coming of age, particularly in industrial settings. As with many new techniques, initial claims regarding ...

Respiratory infections such as COVID-19 have been responsible for numerous pandemics and have placed a substantial burden on ...

A novel microfluidic chip device for the isolation and analysis of circulating tumour cells (CTCs) in breast cancer has been ...

A research group has developed a technology for mass-producing uniform artificial cells (lipid bilayer vesicles) with artificial model nuclei using microfluidic devices with high reproducibility. They ...

Researchers have created a microfluidic device that can reliably make cell structures that are similar to early-stage human embryos without using actual embryonic tissue (Nature 2019, DOI: 10.1038 ...

The new system, known as microfluidic EM-based polyclonal epitope mapping (mEM), offers researchers faster, clearer insights ...

The global microfluidics market, valued at approximately USD 28.65 billion in 2022, is poised for robust growth, with a projected compound annual growth rate (CAGR) of over 12.22% from 2023 to 2030.

Microfluidic chips are particularly promising in cancer diagnosis. In most cases, a tissue biopsy is the initial means of making a diagnosis. With increasing accuracy, liquid biopsies – where ...

Researchers develop a porous nickel-modified graphene fiber that enhances energy density, conductivity, and durability in flexible supercapacitor devices.

Microfluidic Lab-on-a-Chip Devices aid Diagnostics. While microfluidic chips offered improvements to cell culture practices at the lab bench, the medical field wasn’t far behind in their adoption.

Figure 1. Experimental setup to monitor oxygenation in microfluidic cell culture. (A) The microfluidic device consists of a microscope slide as transparent and rigid support, the commercial oxygen ...